Sandu Pharmaceuticals Ltd
SANDUPHQSandu Pharmaceuticals Ltd
SANDUPHQ
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 43.82 | 1.62 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.05 | 9.77 | 1.49% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sandu Pharmaceuticals is engaged in manufacturing and marketing of ayurvedic medicine
Peers
Compare with peersGodrej Consumer Products Ltd
Dabur India Ltd
Marico Ltd
Colgate-Palmolive (India) Ltd
Procter & Gamble Hygiene and Health Care Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44.55 | 46.20 | 43.38 | 49.14 | 49.99 | 48.82 | 58.95 | 65.58 | 65.68 | 66.78 | ||||||||||
Raw Materials | 20.59 | 21.86 | 24.83 | 29.36 | 26.91 | 26.15 | 31.11 | 62.63 | 34.27 | 64.13 | ||||||||||
| Power & Fuel Cost | 0.51 | 0.40 | 0.23 | 0.32 | 0.33 | 0.33 | 0.33 | 0.39 | ||||||||||||
| Employee Cost | 3.69 | 4.51 | 5.42 | 5.94 | 6.49 | 6.85 | 8.02 | 11.10 | ||||||||||||
| Selling & Administrative Expenses | 14.09 | 15.70 | 6.31 | 8.19 | 10.79 | 10.28 | 8.31 | 13.75 | ||||||||||||
| Operating & Other expenses | 3.09 | 0.71 | 4.18 | 2.75 | 2.81 | 3.31 | 8.83 | 3.35 | ||||||||||||
EBITDA | 2.58 | 3.02 | 2.41 | 2.58 | 2.66 | 1.90 | 2.35 | 2.95 | 2.82 | 2.65 | ||||||||||
| Depreciation/Amortization | 0.57 | 0.69 | 0.87 | 0.60 | 0.64 | 0.55 | 0.56 | 0.53 | 0.52 | 0.51 | ||||||||||
| PBIT | 2.01 | 2.33 | 1.54 | 1.98 | 2.02 | 1.35 | 1.79 | 2.42 | 2.30 | 2.14 | ||||||||||
| Interest & Other Items | 1.37 | 1.64 | 1.49 | 1.23 | 1.01 | 0.43 | 0.11 | 0.11 | 0.08 | 0.07 | ||||||||||
| PBT | 0.64 | 0.69 | 0.05 | 0.75 | 1.01 | 0.92 | 1.68 | 2.31 | 2.22 | 2.07 | ||||||||||
| Taxes & Other Items | 0.22 | 0.15 | 0.50 | 0.20 | 0.35 | 0.20 | 0.59 | 0.73 | 0.69 | 0.62 | ||||||||||
| Net Income | 0.42 | 0.54 | -0.45 | 0.55 | 0.66 | 0.72 | 1.09 | 1.58 | 1.53 | 1.45 | ||||||||||
| EPS | 0.59 | 0.76 | -0.64 | 0.78 | 0.93 | 1.02 | 1.45 | 1.99 | 1.66 | 1.50 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | — | 0.00 | 0.75 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.50 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Consumer StaplesFMCG - Personal Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sandu Pharmaceuticals Ltd | 41.53 | 1.62 | — |
| Godrej Consumer Products Ltd | 60.57 | 7.48 | — |
| Dabur India Ltd | 55.85 | 10.10 | 0.96% |
| Marico Ltd | 53.46 | 17.60 | 0.83% |
Price Comparison
Compare SANDUPHQ with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 9.51%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹0.75
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateSep 23, 2022
Dividend/Share
₹0.75
Ex DateEx Date
Sep 23, 2022
Cash Dividend
Ex DateEx DateSep 22, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 22, 2021
News & Opinions
Why are shares of JP Associates, Va Tech Wabag, JP Power, Rail Vikas Nigam and Sandu Pharma, rallying today?
11 months ago•Business Today
Board of Board of Sandu Pharmaceuticals recommends revised final dividend
1 year ago•Business Standard
Sandu Pharma chairman passes away
2 years ago•The Hindu
Sandu Pharmaceuticals’ Goa plant suffers fire accident due to cyclone Tauktae
2 years ago•India Infoline
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 5.97%, vs industry avg of 7.58%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.13% to 0.12%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 22.71%, vs industry avg of 6.14%